Study links acetaminophen use in pregnancy to increased ADHD risk

Recent research has highlighted the potential long-term health impacts of ADHD, including a significant reduction in life expectancy, particularly for women and men diagnosed with the disorder. Studies suggest that a commonly used blood pressure medication, amlodipine, could serve as a promising new treatment for ADHD symptoms, showing effectiveness in both animal models and human data. Amlodipine demonstrated a reduction in hyperactivity and impulsivity while presenting a safer profile compared to traditional ADHD medications, which often carry significant side effects. Researchers found that ADHD is linked to certain brain calcium channels targeted by amlodipine, indicating a potential pathway for treatment. As ADHD affects millions in the U.S. and is often misdiagnosed, these findings could lead to better management options for those suffering from the disorder. Experts are calling for a reevaluation of ADHD treatment strategies in light of these discoveries.